Postoperative medication for cervical precancerous lesions

Cervical precancerous lesions are a relatively common disease, and there is a trend of younger people getting the disease. Generally speaking, the cure rate is very high after early tumors are removed. However, no doctor dares to say that there will be no recurrence. This is because surgery only removes visible tumor cells, and invisible tumor cells cannot be removed. Chemotherapy can only kill a certain percentage of tumor cells, and it is impossible to kill them completely.

In recent years, chemotherapy for tumors has progressed rapidly and plays an important role in the treatment of cervical precancerous lesions. Most cervical precancerous lesions respond well to chemotherapy, which plays a positive role in improving the treatment of cervical precancerous lesions. It can be used as an auxiliary treatment for surgery and is often used before, during and after surgery, but it often requires intermittent medication for a long period of time, and the toxic reaction to the human body is sometimes large.

With the continuous development of medicine, tumor biotherapy has become a commonly used auxiliary treatment method in clinical practice and is recognized as a method that has the potential to completely kill tumor cells. Tumor biotherapy achieves the purpose of treating tumors without destroying the function of the body's immune system. It mainly uses biotechnology to cultivate autologous immune cells that kill tumors in standard laboratories, and then infuse them back into the body to directly kill cancer cells. Different from traditional treatment methods, tumor biotherapy mainly mobilizes the body's natural anti-cancer ability and restores the balance of the body's internal environment.